1355334|t|Monoaminergic and cholinergic synaptic markers in the nucleus basalis of Meynert (nbM): normal age-related changes and the effect of heart disease and Alzheimer's disease.
1355334|a|Neurotransmitter markers for acetylcholine, serotonin (5-HT), and dopamine (DA) were measured in autopsied human nucleus basalis of Meynert (nbM) from nondemented individuals without heart disease (non-HD) (age range, 4-84 years; n = 77), nondemented individuals with heart disease (HD) (age range, 57-92 years; n = 23), and individuals with Alzheimer's disease (AD) (age range, 59-92 years; n = 22). No significant differences in any chemical marker were found between age-matched HD and non-HD individuals. The activities of choline acetyltransferase (ChAT) and acetylcholinesterase (AChE), and [3H]spiperone binding were regionally distributed within the nbM in control (non-HD) subjects less than 54 years of age. The activity of AChE, 5-[3H]HT binding, and the content of homovanillic acid (HVA), 5-hydroxyindoleacetic acid (5-HIAA), and 5-HT were regionally distributed in the nbM in non-HD, HD, and AD subjects more than 54 years of age. The binding of [3H]spiperone was regionally distributed in the nbM in HD and AD subjects more than 54 years of age, only. Activity of ChAT and AChE, content of 5-HT, 5-HIAA, and DA, binding of 5-[3H]HT, and the turnover number for DA (ratio of HVA/DA) all decreased with increasing age in the non-HD control population. The content of HVA, binding of [3H]spiperone, and the turnover number for 5-HT (ratio of 5-HIAA/5-HT) did not change with increasing age. Significant reductions in ChAT and AChE activities were found in AD nbM compared with postmortem interval- and age-matched HD and non-HD individuals. The reduction of 5-HT and 5-HIAA content and [3H]spiperone binding in individuals with AD of all ages suggests a loss of functional serotonergic innervation of the nbM. Dopaminergic synaptic markers were less affected in AD nbM, although turnover numbers for both DA and 5-HT were increased in AD. Receptor upregulation in response to presynaptic deficits did not occur for DA or 5-HT.
1355334	133	146	heart disease	Disease	MESH:D006331
1355334	151	170	Alzheimer's disease	Disease	MESH:D000544
1355334	201	214	acetylcholine	Chemical	MESH:D000109
1355334	216	225	serotonin	Chemical	MESH:D012701
1355334	227	231	5-HT	Chemical	MESH:D012701
1355334	238	246	dopamine	Chemical	MESH:D004298
1355334	248	250	DA	Chemical	MESH:D004298
1355334	279	284	human	Species	9606
1355334	355	368	heart disease	Disease	MESH:D006331
1355334	374	376	HD	Disease	MESH:D006331
1355334	440	453	heart disease	Disease	MESH:D006331
1355334	455	457	HD	Disease	MESH:D006331
1355334	514	533	Alzheimer's disease	Disease	MESH:D000544
1355334	535	537	AD	Disease	MESH:D000544
1355334	654	656	HD	Disease	MESH:D006331
1355334	665	667	HD	Disease	MESH:D006331
1355334	699	724	choline acetyltransferase	Gene	1103
1355334	726	730	ChAT	Gene	1103
1355334	736	756	acetylcholinesterase	Gene	43
1355334	758	762	AChE	Gene	43
1355334	770	782	3H]spiperone	Chemical	-
1355334	850	852	HD	Disease	MESH:D006331
1355334	906	910	AChE	Gene	43
1355334	912	920	5-[3H]HT	Chemical	-
1355334	949	966	homovanillic acid	Chemical	MESH:D006719
1355334	968	971	HVA	Chemical	MESH:D006719
1355334	974	1000	5-hydroxyindoleacetic acid	Chemical	MESH:D006897
1355334	1002	1008	5-HIAA	Chemical	MESH:D006897
1355334	1015	1019	5-HT	Chemical	MESH:D012701
1355334	1066	1068	HD	Disease	MESH:D006331
1355334	1070	1072	HD	Disease	MESH:D006331
1355334	1078	1080	AD	Disease	MESH:D000544
1355334	1133	1145	3H]spiperone	Chemical	-
1355334	1187	1189	HD	Disease	MESH:D006331
1355334	1194	1196	AD	Disease	MESH:D000544
1355334	1251	1255	ChAT	Gene	1103
1355334	1260	1264	AChE	Gene	43
1355334	1277	1281	5-HT	Chemical	MESH:D012701
1355334	1283	1289	5-HIAA	Chemical	MESH:D006897
1355334	1295	1297	DA	Chemical	MESH:D004298
1355334	1310	1318	5-[3H]HT	Chemical	-
1355334	1348	1350	DA	Chemical	MESH:D004298
1355334	1361	1364	HVA	Chemical	MESH:D006719
1355334	1365	1367	DA	Chemical	MESH:D004298
1355334	1414	1416	HD	Disease	MESH:D006331
1355334	1452	1455	HVA	Chemical	MESH:D006719
1355334	1469	1481	3H]spiperone	Chemical	-
1355334	1511	1515	5-HT	Chemical	MESH:D012701
1355334	1526	1532	5-HIAA	Chemical	MESH:D006897
1355334	1533	1537	5-HT	Chemical	MESH:D012701
1355334	1601	1605	ChAT	Gene	1103
1355334	1610	1614	AChE	Gene	43
1355334	1640	1642	AD	Disease	MESH:D000544
1355334	1698	1700	HD	Disease	MESH:D006331
1355334	1709	1711	HD	Disease	MESH:D006331
1355334	1742	1746	5-HT	Chemical	MESH:D012701
1355334	1751	1757	5-HIAA	Chemical	MESH:D006897
1355334	1771	1783	3H]spiperone	Chemical	-
1355334	1812	1814	AD	Disease	MESH:D000544
1355334	1946	1948	AD	Disease	MESH:D000544
1355334	1989	1991	DA	Chemical	MESH:D004298
1355334	1996	2000	5-HT	Chemical	MESH:D012701
1355334	2019	2021	AD	Disease	MESH:D000544
1355334	2099	2101	DA	Chemical	MESH:D004298
1355334	2105	2109	5-HT	Chemical	MESH:D012701
1355334	Association	MESH:D006719	43
1355334	Positive_Correlation	MESH:D006897	MESH:D000544
1355334	Association	MESH:D012701	MESH:D006331
1355334	Association	MESH:D006331	43
1355334	Association	MESH:D006897	MESH:D006331
1355334	Association	MESH:D000544	43
1355334	Association	MESH:D012701	MESH:D000544

